0001209191-23-010607.txt : 20230217
0001209191-23-010607.hdr.sgml : 20230217
20230217162244
ACCESSION NUMBER: 0001209191-23-010607
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chacko Jacob
CENTRAL INDEX KEY: 0001608936
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39269
FILM NUMBER: 23642927
MAIL ADDRESS:
STREET 1: C/O IGNYTA, INC.
STREET 2: 11095 FLINTKOTE AVE., SUITE D
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oric Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001796280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471787157
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 388-5600
MAIL ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-12-15
2022-12-16
0
0001796280
Oric Pharmaceuticals, Inc.
ORIC
0001608936
Chacko Jacob
C/O ORIC PHARMACEUTICALS, INC.
240 E. GRAND AVE., 2ND FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Common Stock
2022-12-15
4
S
0
6137
3.073
D
816652
D
This amendment is filed to correct the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person.
/s/ Christian Kuhlen, attorney-in-fact
2023-02-17